Latest Close
$24.35
News
ARQT
Arcutis Biotherapeutics, Inc. News
This news view pulls recent coverage and headlines tied to ARQT.
1y Change
$11.41 (+88.18%)
Market Cap
$3.02B
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Is It Too Late To Revisit Arcutis Biotherapeutics (ARQT) After A 75% One-Year Surge?
Simply Wall St. • Apr 8, 2026
Read articleArcutis Stock Up 65% as Director Sells 10,000 Shares Under 10b5-1 Plan. Here's What Investors Should Know
Motley Fool • Apr 8, 2026
Read articleHow The Arcutis Biotherapeutics (ARQT) Story Is Evolving As Analysts Cluster Around US$35 Targets
Simply Wall St. • Apr 8, 2026
Read articlePalvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
GlobeNewswire • Apr 7, 2026
Read articleArcutis Management to Present at the 25th Annual Needham Virtual Healthcare Conference
GlobeNewswire • Mar 31, 2026
Read articleArcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting
GlobeNewswire • Mar 28, 2026
Read article